Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 8, 1999

View Archived Issues

CRCT and Duke receive US BRCA2 gene patent

BioSpecifics announces results of injectable collagenase phase II study

Schering Berlin completes acquisition of Diatide

SmithKline Beecham licenses antigen technology from Cortecs

Nasonex Nasal Spray approved in E.U. for use in young children

Vasogen study shows VasoCare therapy improves blood flow in patients with PVD

Zeria evaluates potential cognition enhancer in healthy volunteers

Interim data fom phase II IntraDose trial in liver cancer indicate positive response

Glaxo Wellcome files for approval of new Relenza indications: influenza prophylaxis, pediatric use

Pharmacia & Upjohn describes anthracycline glycosides and their antitumor activity

Azacycloalkane derivatives from Sanofi-Synthelabo with dual hypoglycemic/antiinflammatory actions

Dopaminergic compounds disclosed by AHP for Parkinson's disease, schizophrenia, etc.

Newly issued patent covers Esteve's novel analgesic agents

Amgen's epoetin alfa approved in children with chronic renal failure

Antiviral agents discovered at U. of Michigan

Alpha2-adrenoceptor ligands from Ortho-McNeil with analgesic and other pharmacological effects

Landmark study in type II diabetics assesses long-term efficacy of Avandia

Potential interaction between S-4661 and valproic acid

Metabolism of S-2150 elucidated in two studies presented at Xenobiotics meeting

Inhibitex enters collaboration with ZLB for S. aureus antiinfective agents

TKS-159: metabolism of new GI prokinetic agent and comparison with other benzamides

Novartis presents phase I results for transplant drug at ASN

Idun identifies X-ray structure of caspase 8

Novel class of bifunctional anticancer agents discovered at University of Kansas

Visudyne submitted for marketing approval in Canada

News from ASN: PDGF tyrosine kinase is a target for intervention in renal diseases

Antifibrotic agent pirfenidone slows the progression of glomerulosclerosis

Stabilized 99mTc complex RP-463 for imaging infections

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....